[Therapeutic drug monitoring of disopyramide, mexiletine, aprindine and beta blockers].
Suzuki
M
M
Research Center of Comprehensive Medicine, School of Medicine, University of the Ryukyus.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D001073:Aprindine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000378:metabolism; D001682:Biological Availability; D002849:Chromatography, Gas; D002851:Chromatography, High Pressure Liquid; D004206:Disopyramide / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007192:Indenes / Q000493:pharmacokinetics*; D008801:Mexiletine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D013050:Spectrometry, Fluorescence
D000319:Adrenergic beta-Antagonists; D007192:Indenes; D008801:Mexiletine; D001073:Aprindine; D004206:Disopyramide